Trial Profile
An open-label evaluation of the utility of the Risperdal Consta treatment guidebook during transition of adult patients with schizophrenia or schizoaffective disorder to Risperdal Consta (risperidone) treatment over three months in the community mental health center (CMHC) setting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2007
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 14 Oct 2006 New trial record.